What’s Happening With Our Partners

Phoenix Children’s Launches Corporate Venture Studio in Partnership with Coplex.

PHOENIX — May 17, 2022 — Phoenix Children’s, one of the nation’s largest pediatric health systems, recently announced a partnership with Coplex (coplex.com), a leading venture studio and corporate innovation firm, to launch six new health care technology startups over the next three years.

Blackpearl Group acquires the Newoldstamp with a team in Ukraine for $3,1M

On November 1, 2022, the New Zealand company Blackpearl Group announced the acquisition of the NewOldStamp product and business with the team in Ukraine. The consideration for the deal was about $3.1 million, as the company told AIN.Capital.

Toothio is here and it’s changing the way we staff our practices

TEMPE, Ariz., Aug. 12, 2022 /PRNewswire/ — Gone are the days of scrambling to find a Hygienist; unsure of who to call or who will show up if you do manage to find someone. This pain has become all too familiar in recent years.

Last October, Toothio Co-founder Ian Prendergast got a call from Doctor Ken Baker that set Toothio in motion. “We are really struggling to find staff to run our practices. Interviews are hard to secure and “temp” options are low quality and unreliable,” said Baker. “The entire industry is really feeling it.”

‘Tech acquisition’ company Blackpearl Group to list on NZX

Blackpearl Group describes itself as a technology company that builds, acquires, and markets data-driven cloud services. These consist of a suite of productivity and demand generation applications for small and medium-sized businesses.

Freestar Named to the Inc. 5000 List of Fastest-Growing Companies in the US for the Fourth Year in a Row

PHOENIX, Aug. 16, 2022 (GLOBE NEWSWIRE) — Freestar, the leading monetization partner for content publishers, e-commerce sites, and app developers, announced today that it has earned another spot on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in the U.S, for the fourth consecutive year coming in at No. 1824. Its three-year revenue growth rate of 334% allowed the company to remain in the top 2,000 each year after earning the No. 1 ranking in 2019.

Nocira: Potential Game Changer in Migraine Treatment

In the dynamic world of medical devices, one of the biggest challenges can be changing the standards of care, even if they underserve the market, with disruptive technology. This is especially true for transforming drug-dominating markets toward new device alternatives.

NOCIRA® Becomes First Company Ever to Announce “Breakthrough Device” Designation by the FDA for Acute Treatment of Migraine

NOCIRA®’s hand-held device that uses gentle, controlled puffs of air in the ears for treating migraine attacks is now designated by the FDA as a “Breakthrough Device.”

NOCIRA is the first company to announce FDA’s Breakthrough Device designation for treating migraine attacks in both chronic and non-chronic migraine patients

Phoenix tech startup named fastest-growing private company in the nation

This Phoenix company helps online publishers monetize web traffic by handling advertising operations for busy websites. Company executives spoke to the Business Journal about their “rocket ship” ride in the past four years, and what’s coming next.

Nocira’s migraine treatment device gets FDA breakthrough designation

The US Food and Drug Administration (FDA) has granted breakthrough designation for Nocira’s hand-held device to treat acute migraine in patients aged 18 years or above.

Named Automated Variable Pulse Insufflation (AVPI), the device uses gentle, controlled puffs of air in the ears to treat migraine attacks. A non-invasive and drug-free device, the AVPI system treats migraine attacks by regulating gentle pressure changes in the external ear canal.